About

Eone-Diagnomics Genome Center (EDGC) is a premier global genomics and precision medicine company based in Songdo, Incheon, South Korea. Founded by Dr. Min Seob Lee, a renowned genomics scientist and entrepreneur with over three decades of international experience in the United States and Asia, EDGC is dedicated to advancing the future of healthcare through cutting-edge genomic technologies. Dr. Lee, who previously worked at leading institutions such as Sequenom and Harvard Medical School, serves as Chairman and CEO of EDGC, bringing his vision for data-driven, accessible precision medicine to life.

As a joint venture originally formed with Diagnomics Inc. in San Diego, EDGC bridges East and West in its pursuit of innovation, integrating next-generation sequencing (NGS), cell-free DNA (cfDNA) technologies, and AI-powered bioinformatics to deliver high-quality genomic solutions. EDGC operates CLIA- and CAP-accredited laboratories and provides clinical-grade genomic testing, including non-invasive prenatal testing (NIPT), liquid biopsy for early cancer detection, hereditary disease screening, methylation-based biological age analysis (EpiClock), and genetic wellness services.

With more than 10 years of experience in cfDNA-based diagnostics, EDGC holds a dominant position in Korea’s NIPT market, representing over 50% of the domestic volume, and serves healthcare providers and research partners in more than 30 countries. The company has built one of the largest cfDNA genomic databases in Asia and is now expanding its capabilities into epigenomics, microbiome profiling, and AI-driven predictive modeling for personalized health.

EDGC’s long-term strategy focuses on enabling lifespan medicine—the proactive management of health throughout the human lifecycle—by combining genomics, wearable data, AI, and multi-omics analytics. Through its proprietary platforms and global partnerships, EDGC is actively involved in drug discovery, clinical trials, and real-world evidence (RWE) generation, positioning itself as a leading player in the convergence of biotechnology, data science, and preventative healthcare.

Under Dr. Min Seob Lee’s leadership, EDGC is committed to building a world where genomic information becomes a universal tool for early diagnosis, personalized treatment, and longevity. With deep scientific expertise, global infrastructure, and a relentless focus on innovation, EDGC is spearheading the next era of DNA-based healthcare.